Examining Hepatitis C Virus Treatment Access
A Review of Select State Medicaid Fee-For-Service and Managed Care Programs
Last Updated on May 13, 2020 by HepFree NYC
Related Articles
-
CDC Viral Hepatitis Strategic Plan – 2020
This Plan updates the Center’s current strategic plan and serves as a blueprint for achieving our vision of a future free of HIV, viral hepatitis, STDs, and TB.
-
NYC Health Dept Hep B & C Annual Report of Activities (2015)
This report presents an overview of the New York City Health Department’s 2015 surveillance and research data on hepatitis B and C in NYC, as well as the Health Department’s programmatic activities to address these epidemics.
-
Support WHO Hepatitis Strategy
Support the World Health Organization's Viral Hepatitis Strategy by sending a letter to Secretary Burwell
-
FDA Approves Zepatier for Treatment of Hep C
The U.S. Food and Drug Administration has approved Zepatier with or without ribavirin for the treatment of chronic Hepatitis C genotypes 1 and 4 infections in adult patients.
-
US Congress Eases Funding Restrictions for Syringe Access Programs
The US Senate and House of Representatives has eased restrictions on federal funding for elements of syringe access programs
-
Survey | Medicaid & Medication Issues: Chance to win $100!
Are you on Medicaid and receive medication coverage information from one of the plans below?
-
Dear Colleague Letter | Hep B & C Screening & Treatment Guidance 2020 (NYC Health Dept)
In March 2020, the United States Preventive Services Task Force recommended one-time screening for hepatitis C in people aged 18-79. Simplified treatment guidance has been developed for hepatitis B and C.
-
New NYS Law | RNs Authorized to Administer Hep C Test Without Physician Orders
Governor Andrew M. Cuomo today signed into law a bill that increases access to hepatitis C, or HCV, tests by allowing physicians and nurse practitioners to authorize registered nurses, when appropriate, to administer the test to a patient without the need for a patient-specific o...
